These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33994370)

  • 21. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas.
    Lassmann S; Weis R; Makowiec F; Roth J; Danciu M; Hopt U; Werner M
    J Mol Med (Berl); 2007 Mar; 85(3):293-304. PubMed ID: 17143621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression.
    Carvalho B; Postma C; Mongera S; Hopmans E; Diskin S; van de Wiel MA; van Criekinge W; Thas O; Matthäi A; Cuesta MA; Terhaar Sive Droste JS; Craanen M; Schröck E; Ylstra B; Meijer GA
    Gut; 2009 Jan; 58(1):79-89. PubMed ID: 18829976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Copy number changes of clinically actionable genes in melanoma, non-small cell lung cancer and colorectal cancer-A survey across 822 routine diagnostic cases.
    Pfarr N; Penzel R; Klauschen F; Heim D; Brandt R; Kazdal D; Jesinghaus M; Herpel E; Schirmacher P; Warth A; Weichert W; Endris V; Stenzinger A
    Genes Chromosomes Cancer; 2016 Nov; 55(11):821-33. PubMed ID: 27218826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic amplification of chromosome 20q13.33 is the early biomarker for the development of sporadic colorectal carcinoma.
    Bui VM; Mettling C; Jou J; Sun HS
    BMC Med Genomics; 2020 Oct; 13(Suppl 10):149. PubMed ID: 33087131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells.
    Savelieva E; Belair CD; Newton MA; DeVries S; Gray JW; Waldman F; Reznikoff CA
    Oncogene; 1997 Feb; 14(5):551-60. PubMed ID: 9053853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression.
    Sillars-Hardebol AH; Carvalho B; Beliën JA; de Wit M; Delis-van Diemen PM; Tijssen M; van de Wiel MA; Pontén F; Meijer GA; Fijneman RJ
    Cell Oncol (Dordr); 2012 Aug; 35(4):293-300. PubMed ID: 22711543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The AURKA/TPX2 axis drives colon tumorigenesis cooperatively with MYC.
    Takahashi Y; Sheridan P; Niida A; Sawada G; Uchi R; Mizuno H; Kurashige J; Sugimachi K; Sasaki S; Shimada Y; Hase K; Kusunoki M; Kudo S; Watanabe M; Yamada K; Sugihara K; Yamamoto H; Suzuki A; Doki Y; Miyano S; Mori M; Mimori K
    Ann Oncol; 2015 May; 26(5):935-942. PubMed ID: 25632068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series.
    Domingo E; Camps C; Kaisaki PJ; Parsons MJ; Mouradov D; Pentony MM; Makino S; Palmieri M; Ward RL; Hawkins NJ; Gibbs P; Askautrud H; Oukrif D; Wang H; Wood J; Tomlinson E; Bark Y; Kaur K; Johnstone EC; Palles C; Church DN; Novelli M; Danielsen HE; Sherlock J; Kerr D; Kerr R; Sieber O; Taylor JC; Tomlinson I
    Lancet Gastroenterol Hepatol; 2018 Sep; 3(9):635-643. PubMed ID: 30042065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gain of chromosomal region 20q and loss of 18 discriminates between Lynch syndrome and familial colorectal cancer.
    Therkildsen C; Jönsson G; Dominguez-Valentin M; Nissen A; Rambech E; Halvarsson B; Bernstein I; Borg K; Nilbert M
    Eur J Cancer; 2013 Apr; 49(6):1226-35. PubMed ID: 23245329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amplification of 8p11.23 in cancers and the role of amplicon genes.
    Voutsadakis IA
    Life Sci; 2021 Jan; 264():118729. PubMed ID: 33166592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas.
    Douglas EJ; Fiegler H; Rowan A; Halford S; Bicknell DC; Bodmer W; Tomlinson IP; Carter NP
    Cancer Res; 2004 Jul; 64(14):4817-25. PubMed ID: 15256451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amplicon-dependent CCNE1 expression is critical for clonogenic survival after cisplatin treatment and is correlated with 20q11 gain in ovarian cancer.
    Etemadmoghadam D; George J; Cowin PA; Cullinane C; Kansara M; ; Gorringe KL; Smyth GK; Bowtell DD
    PLoS One; 2010 Nov; 5(11):e15498. PubMed ID: 21103391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers.
    Letessier A; Sircoulomb F; Ginestier C; Cervera N; Monville F; Gelsi-Boyer V; Esterni B; Geneix J; Finetti P; Zemmour C; Viens P; Charafe-Jauffret E; Jacquemier J; Birnbaum D; Chaffanet M
    BMC Cancer; 2006 Oct; 6():245. PubMed ID: 17040570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chr20q Amplification Defines a Distinct Molecular Subtype of Microsatellite Stable Colorectal Cancer.
    Zhang B; Yao K; Zhou E; Zhang L; Cheng C
    Cancer Res; 2021 Apr; 81(8):1977-1987. PubMed ID: 33619118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular biology of colorectal cancer.
    Gryfe R; Swallow C; Bapat B; Redston M; Gallinger S; Couture J
    Curr Probl Cancer; 1997; 21(5):233-300. PubMed ID: 9438104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gain of chromosome 20q is an indicator of poor prognosis in colorectal cancer.
    Postma C; Terwischa S; Hermsen MA; van der Sijp JR; Meijer GA
    Cell Oncol; 2007; 29(1):73-5. PubMed ID: 17429145
    [No Abstract]   [Full Text] [Related]  

  • 37. Genomic alterations in signet ring and mucinous patterned colorectal carcinoma.
    Kim H; Kim BH; Lee D; Shin E
    Pathol Res Pract; 2019 Oct; 215(10):152566. PubMed ID: 31400926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients.
    Diep CB; Thorstensen L; Meling GI; Skovlund E; Rognum TO; Lothe RA
    J Clin Oncol; 2003 Mar; 21(5):820-9. PubMed ID: 12610180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness.
    Schmidt U; Heller G; Timelthaler G; Heffeter P; Somodi Z; Schweifer N; Sibilia M; Berger W; Csiszar A
    J Exp Clin Cancer Res; 2021 Feb; 40(1):69. PubMed ID: 33596971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased frequency of 20q gain and copy-neutral loss of heterozygosity in mismatch repair proficient familial colorectal carcinomas.
    Middeldorp A; van Eijk R; Oosting J; Forte GI; van Puijenbroek M; van Nieuwenhuizen M; Corver WE; Ruano D; Caldes T; Wijnen J; Morreau H; van Wezel T
    Int J Cancer; 2012 Feb; 130(4):837-46. PubMed ID: 21445971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.